Busulfan with fludarabine myeloablative conditioning regimen in myeloid neoplasms: A single center experience.

被引：0
|
作者：
Raj, Renju V.
Button, Anna M.
Dozeman, Lindsay
De Magalhaes-Silverman, Margarida
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e18000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18000
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major
    Roswitha Lüftinger
    Natalia Zubarovskaya
    Jacques-Emmanuel Galimard
    Annamaria Cseh
    Elisabeth Salzer
    Franco Locatelli
    Mattia Algeri
    Akif Yesilipek
    Josu de la Fuente
    Antonella Isgrò
    Amal Alseraihy
    Emanuele Angelucci
    Frans J. Smiers
    Giorgia La La Nasa
    Marco Zecca
    Tunc Fisgin
    Emel Unal
    Katharina Kleinschmidt
    Christina Peters
    Arjan Lankester
    Selim Corbacioglu
    Annals of Hematology, 2022, 101 : 655 - 665
  • [32] Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major
    Luftinger, Roswitha
    Zubarovskaya, Natalia
    Galimard, Jacques-Emmanuel
    Cseh, Annamaria
    Salzer, Elisabeth
    Locatelli, Franco
    Algeri, Mattia
    Yesilipek, Akif
    de la Fuente, Josu
    Isgro, Antonella
    Alseraihy, Amal
    Angelucci, Emanuele
    Smiers, Frans J.
    Nasa, Giorgia La La
    Zecca, Marco
    Fisgin, Tunc
    Unal, Emel
    Kleinschmidt, Katharina
    Peters, Christina
    Lankester, Arjan
    Corbacioglu, Selim
    ANNALS OF HEMATOLOGY, 2022, 101 (03) : 655 - 665
  • [33] Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients
    Toshiro Kawakita
    Taichi Hirano
    Yoshitaka Inoue
    Yumiko Irie
    Hironori Sugitani
    Akira Kubota
    Miho Watanabe
    Mitsunori Ueno
    Norikazu Mitsui
    Shunichiro Yamaguchi
    Yoshiko Inoue
    Tatsunori Sakai
    Naoko Harada
    Masao Matsuoka
    Michihiro Hidaka
    International Journal of Hematology, 2021, 114 : 85 - 93
  • [34] Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients
    Kawakita, Toshiro
    Hirano, Taichi
    Inoue, Yoshitaka
    Irie, Yumiko
    Sugitani, Hironori
    Kubota, Akira
    Watanabe, Miho
    Ueno, Mitsunori
    Mitsui, Norikazu
    Yamaguchi, Shunichiro
    Inoue, Yoshiko
    Sakai, Tatsunori
    Harada, Naoko
    Matsuoka, Masao
    Hidaka, Michihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (01) : 85 - 93
  • [35] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [36] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [37] Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation
    Abedin, Sameem
    Peres, Edward
    Levine, John E.
    Choi, Sung
    Yanik, Gregory
    Couriel, Daniel R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 2062 - 2066
  • [38] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    M Iravani
    M R Evazi
    S A Mousavi
    A R Shamshiri
    M Tavakoli
    A Ashouri
    S Samiee
    B Chahardovali
    K Alimoghaddam
    S H Ghaffari
    A Ghavamzadeh
    Bone Marrow Transplantation, 2007, 40 : 105 - 110
  • [39] Busulfan and fludarabine is a safe and effective conditioning regimen for allogenic bone marrow transplantation in adults with acute myeloid leukaemia
    Fagot, T.
    Konopacky, J.
    Malfusion, J. V.
    Doghmi, K.
    Raffoux, E.
    Samson, T.
    Foissaud, V.
    Souleau, B.
    Janus, G.
    Bories, D.
    De Revel, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S111 - S112
  • [40] Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
    Liu, Hui
    Zhai, Xiao
    Song, Zhaoyang
    Sun, Jing
    Xiao, Yang
    Nie, Danian
    Zhang, Yu
    Huang, Fen
    Zhou, Hongsheng
    Fan, Zhiping
    Tu, Sanfang
    Li, Yonghua
    Guo, Xutao
    Yu, Guopan
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
12345